Pc3 - OmicsDI

Show results for

Unknown (1579)
Transcriptomics (516)
Genomics (484)
Proteomics (65)
Other (13)
Methylation profiling (6)
Metabolomics (3)

Organisms

Homo sapiens (534)
Andropogon gerardi (44)
Bacteria (44)
Bartonella quintana JK 31 (44)
Canis lupus familiaris (44)
Cnidaria (44)
Ensifer adhaerens (44)
Halictus scabiosae (44)
Human alphaherpesvirus 1 strain 17 (44)
Human alphaherpesvirus 1 strain KOS (44)
Human betaherpesvirus 5 (44)
Human herpesvirus 2 strain 186 (44)
Mesocricetus auratus (44)
Mus musculus (39)
Arabidopsis thaliana (6)
Rattus norvegicus (5)
synthetic construct (2)
uncultured Pseudomonas sp. (2)
Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S (1)
Brassica rapa subsp. pekinensis (1)
Zea mays (1)
Oryza sativa Japonica Group (1)
Caenorhabditis elegans (1)
Canis lupus familiaris (1)
Gallus gallus (1)
Saccharomyces cerevisiae (1)
Expression vector lentiGuide-Puro (1)
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 (1)
Salmonella enterica subsp. enterica serovar Typhimurium (1)
Triticum aestivum (1)

Organisms

Homo sapiens (358)
Mus musculus (12)
Bacillus sp. Pc3 (1)
Rhodoblastus acidophilus (1)
Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S (1)
Salmonella enterica subsp. enterica serovar Typhimurium (1)
Triticum aestivum (1)
Rattus norvegicus (1)
synthetic construct (1)

Repository

ENA (432)
biostudies-arrayexpress (328)
geo (255)
pride (44)
MassIVE (11)
jPOST (6)
LINCS (5)
iProX (3)
ExpressionAtlas (2)
MetaboLights (2)
EVA (1)
GNPS (1)
GPMDB (1)
PanoramaPublic (1)

Tissue

Cell culture (18)
Epithelial cell (13)
Epithelial cell of prostate (8)
Prostate cancer cell line (6)
Permanent cell line cell (3)
Cell line cell (2)
Prostate epithelium cell line (2)
Prostate gland (2)
B cell (1)
Blood serum (1)
Breast cancer cell line (1)
Colorectal cancer cell line (1)
Fibroblast (1)
Malignant cell (1)
Mammary gland cell line (1)
Ovary cancer cell (1)
Prostate adenocarcinoma cell line (1)
Prostate cancer cell (1)
Prostate stromal cell (1)

Disease

Prostate adenocarcinoma (23)
Prostate cancer (11)
Prostate carcinoma (5)
Breast cancer (3)
Glioblastoma (2)
Malignant neoplasm of ovary (2)
Pancreatic cancer (1)
Follicular lymphoma (1)
Primary tumor (1)
PC-3/FGF-8b cell inoculated (1)
Cancer (1)
Melanoma (1)
Not Available (1)
Breast fibrocystic disease (1)

Technology Type

Mass Spectrometry (44)
Shotgun proteomics (18)
Bottom-up proteomics (12)
Data-dependent acquisition (8)
Fluorescence intensity (5)
MEMA (5)
Affinity purification coupled with mass spectrometry proteomics (5)
Data-independent acquisition (3)
Gel-based experiment (3)
SWATH MS (3)
Top-down proteomics (2)
Mass spectrometry assay (1)
Mass spectrometry (1)
Affinity proteomics (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
RNA mass spectrometry (1)

Instrument Platform

Illumina HiSeq 2000 (5)
Illumina HiSeq 4000 (5)
NextSeq 500 (5)
Illumina NovaSeq 6000 (3)
Q Exactive Plus (3)
G2565AA DNA microarray scanner [Agilent] (2)
Illumina HiSeq 1000 (2)
Illumina HiSeq 2500 (2)
Q Exactive (2)
Tapestri Platform (1)
IScan Illumina (1)
G2565BA DNA microarray scanner [Agilent] (1)
GenePix 4000B [Axon Instruments] (1)
Illumina NovaSeq X (1)
DNBSEQ-G400 (1)
BGISEQ-500 (1)
NextSeq 550 (1)
- (1)
Impact II (QTOF) (1)
Instrument (1)
6530A Q-TOF LC/MS (1)
LTQ Orbitrap Elite (1)
Orbitrap Eclipse (1)
Orbitrap Fusion (1)
Orbitrap Fusion ETD (1)
Q Exactive HF (1)
Capillary electrophoresis MS - negative (1)
Capillary electrophoresis MS - positive (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2014 (71)
2013 (63)
2016 (54)
2015 (41)
2012 (41)
2010 (35)
2025 (33)
2021 (33)
2024 (31)
2026 (30)
2017 (30)
2011 (30)
2023 (29)
2019 (29)
2020 (26)
2022 (20)
2008 (16)
2009 (13)
2018 (11)
2007 (8)
2006 (6)
2005 (4)
2003 (3)
2004 (2)

CHEBI ID

CHEBI:42111 (1)
CHEBI:15428 (1)

Metabolite Name

Trans-8, trans-10-dodecadien-1-ol (1)
Sulfoxaflor (1)
S-hydroprene (1)
Rac-all-trans-4-hydroxyretinal (1)
N,n-dimethyldodecylamine (1)
N-cyclopentyl-n-phenylamine (1)
Methyl .gamma.-linolenate (1)
Mandelonitrile benzoate (1)
L-beta-homoproline (1)
L-beta-homolysine (1)
Isoxazole, 3-[4-(methylsulfonyl)phenyl]-4-phenyl-5-(trifluoromethyl)- (1)
Dl-leucinamide (1)
Dl-.beta.-homophenylalanine (1)
D-myo-inositol-4-phosphate (1)
Cyclohexanamine, 1-phenyl-n-propyl- (1)
Clopyralid methyl ester (1)
8-acetyl-6,7-dimethoxycoumarin (1)
6-hydroxy-3,4-dihydro-1h-quinoline-2-one (1)
6-aminopyridine-3-carboxamide (1)
5-methyl-5-phenylhydantoin (1)
5-(hydroxymethyl)quinolin-8-ol (1)
4-nitrodiphenylamine (1)
4-nitro-1,3-benzenediamine (1)
4-methylcinnamic acid (1)
4-chlorobenzenesulfonamide (1)
3,3-dimethylacrylic acid (1)
3-methylbuphedrone (1)
3-aminocoumarin (1)
3-amino-4-hydroxybenzoate (1)
3-amino-3-(2-chlorophenyl)propionic acid (1)

First Public Date

2014 (83)
2024 (52)
2025 (43)
2023 (42)
2026 (32)
2019 (31)
2021 (28)
2020 (26)
2022 (22)
2017 (21)
2016 (19)
2015 (14)
2018 (12)
2013 (7)

Classification

bacteria (2)

Modification

15.994915 (1)
32.056407 (1)
42.010565 (1)

Study type

Transcription profiling by array (220)
RNA-seq of coding RNA (28)
ChIP-seq (15)
Other (9)
Methylation profiling by array (9)
Unknown experiment type (7)
MicroRNA profiling by array (5)
Transcription profiling by RT-PCR (4)
Comparative genomic hybridization by array (4)
ChIP-chip by array (3)
Methylation profiling by high throughput sequencing (3)
ChIP-chip by tiling array (2)
Cell line - One-color microarray (2)
Transcription profiling by tiling array (2)
RNAi profiling by array (2)
MicroRNA profiling by high throughput sequencing (2)
DNA-seq (2)
RNA-seq of non coding RNA (2)
MicroRNA profiling by high-throughput sequencing (1)
Cell line - High-throughput sequencing (1)
4C (1)
RIP-seq (1)
RNA-seq of coding RNA from single cells (1)
RNA-seq of total RNA (1)

Release Date

2022 (179)
2021 (158)
2023 (147)
2016 (126)
2025 (124)
2020 (119)
2015 (118)
2014 (118)
2018 (113)
2019 (110)
2017 (105)
2024 (104)
2013 (94)
2010 (67)
2012 (64)
2011 (52)
2009 (30)
2008 (30)
2026 (17)
2007 (10)
2006 (8)
2005 (3)
2002 (3)
2003 (2)
2000 (1)
1998 (1)

Lab affiliation

Departments of Surgery and Biomedical Sciences Cedars-Sinai Medical Center Los Angeles, CA 90048 (2)
Director Stony Brook Cancer Center (2)
AMU, CNRS, INSERM, Institut Paoli-Calmettes, CRCM (1)
Aix-Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes (1)
Associate Prosfessor, Johns Hopkins University, Department of Pathology Baltimore USA (1)
BK21 Plus KNU Multi-Omics based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Republic of Korea (1)
BK21 Plus KNU Multi-Omics-based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Republic of Korea (1)
CRUK Beatson Institute, Switchback Road, Glasgow G61 1BD, UK. (1)
Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver V5Z 1L3, Canada. (1)
Cancer Biology Department, Fox Chase Cancer Center, Philadelphia, PA, USA (1)
Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA, USA (1)
Cedars-Sinai Medical Center (1)
Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, QC, Canada (1)
Centre de Recherche en Cancérologie de Marseille, CRCM Inserm UMR1068, CNRS UMR7258, Aix Marseille Université U105, Institut Paoli Calmettes 27 Boulevard Leï Roure CS30059 13273 Marseille Cedex 09 France (1)
Core Facility Proteomics, Department of Clinical Chemistry, University Medical Center Goettingen, Germany (1)
Department of Biochemistry, University of Turku, Turku, Finland (1)
Department of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. (1)
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, United States (1)
Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden (1)
Department of Neurosurgery, Nanfang hospital, Southern Medical University, Guangzhou 510515,China (1)
Department of Pathology, Department of Urology, Department of Oncology, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21231 (1)
Departments of Surgery and Biomedical Sciences Cedars-Sinai Medical Center Los Angeles, CA United States of America (1)
Division of Signaling and Functional Genomics, German Cancer Research Center Heidelberg Germany (1)
Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Finland (1)
Head of the Curie Institute Mass Spectrometry Platform (1)
Henriette A. Remmer, Ph.D. Director, Proteomics & Peptide Synthesis Core University of Michigan C570C MSRB II SPC 5674 1150 W. Medical Center Drive Ann Arbor, MI 48109 https://brcf.medicine.umich.edu/cores/proteomics-peptide-synthesis/ (1)
Institute of Biomedicine, University of Turku, Finland (1)
Institute of Gene Biology, Russian Academy of Sciences, Group of Chromatin Biology (1)
Laboratory of Peroxisome Biology and Intracellular Communication, Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven, 3000 Leuven, Belgium (1)
Marseille Protéomique, Centre de Recherche en Cancérologie de Marseille, INSERM, CNRS, Institut Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France (1)

Previous page
1 / 267
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 267
Next page

Sort by:

Relevance

Page size

Microarray analysis of PC3 prostate tumor-initiating cells (PC3 holoclones)

BACKGROUND: Cancer stem-like cells are proposed to sustain solid tumors by virtue of their capacity for self-renewal and differentiation to cells that comprise the bulk of the tumor, and have been identified for a variety of cancers based on characteristic clonal morphologies and patterns of marker ...

ORGANISM(S): Homo sapiens

2013-11-07 | E-GEOD-52161 | biostudies-arrayexpress

Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21 [miRNA expression]

The epidemiologic association between statin use and decreased risk of advanced prostate cancer suggests that statins may inhibit prostate cancer development and/or progression. Studies were performed to determine the effects of a model statin, atorvastatin (ATO), on the proliferation and different...

ORGANISM(S): Homo sapiens

2013-09-30 | E-GEOD-46375 | biostudies-arrayexpress

Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21 [Gene expression]

ORGANISM(S): Homo sapiens

2013-09-30 | E-GEOD-46374 | biostudies-arrayexpress

RNAi knock-down of EZH2 in mouse prostate cancer cell line PC3

Gene list with increasing of expression in 2-fold or more after EZH2 knockdown in PC3 cells

ORGANISM(S): Homo sapiens

2008-04-24 | E-MEXP-1581 | biostudies-arrayexpress

Effect of U94 in Gene Expression in PC3 Cells

ORGANISM(S): Homo sapiens

2010-06-10 | E-GEOD-1868 | biostudies-arrayexpress

Rhodoblastus acidophilus strain:PC3

Rhodoblastus strain PC3

PRJNA762293 | ENA

MELK and UBE2C gene knockdown in prostate cancer cell line PC3

In order to address the putative role of MELK and UBE2C in prostate cancer development and progression, we performed functional analysis upon siRNA-based knockdown, and searched for downstream genes and processes by microarray experiments. RNAi-based inhibition of MELK and UBE2C was efficient in PC3...

ORGANISM(S): Homo sapiens

2012-10-19 | E-GEOD-32873 | biostudies-arrayexpress

Bacillus sp. Pc3

Bacillus sp. Pc3 Genome sequencing

PRJNA271045 | ENA

Siomycin A treatment in prostate cancer cell lines PC3 and LNCaP

Siomycin A treatment in prostate cancer cell lines resulted in a concurrent inhibition of specific cell cycle genes and strongly impaired cell viability. Illumina microarray experiments were done using PC3 and LNCaP cell lines treated with 0.5 microM Siomaycin A either 24h or 48h in triplicates.

ORGANISM(S): Homo sapiens

2012-10-19 | E-GEOD-36531 | biostudies-arrayexpress

Homo sapiens strain:PC3

PC3 prostate cancer cell line sequencing

PRJNA361315 | ENA

Previous page
1 / 267
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 267
Next page

Sort by:

Relevance

Page size

2667 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets